A Study to Investigate the Efficacy and Safety with Gepotidacin in Japanese Female Participants with Uncomplicated Urinary Tract Infection (Acute Cystitis)

Trial Identifier: 214144
Sponsor: GlaxoSmithKline
Start Date: January 2023
Primary Completion Date: February 2024
Study Completion Date: February 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Japan Chiba, Japan, 263-0043
Japan Chiba, Japan, 270-0034
Japan Chiba, Japan, 272-0107
Japan Chiba, Japan, 286-0201
Japan Fukuoka, Japan, 810-0001
Japan Fukuoka, Japan, 811-0120
Japan Fukuoka, Japan, 814-0013
Japan Fukuoka, Japan, 816-0943
Japan Gunma, Japan, 370-0826
Japan Hokkaido, Japan, 006-0816
Japan Ibaraki, Japan, 305-0821
Japan Ibaraki, Japan, 300-0062
Japan Kagoshima, Japan, 890-0073
Japan Kanagawa, Japan, 231-0861
Japan Kanagawa, Japan, 232-0067
Japan Kochi, Japan, 781-0085
Japan Miyagi, Japan, 980-0803
Japan Osaka, Japan, 564-0063
Japan Osaka, Japan, 534-0024
Japan Saga, Japan, 840-0831
Japan Saitama, Japan, 360-0012
Japan Saitama, Japan, 352-0001
Japan Tokyo, Japan, 130-0026
Japan Tokyo, Japan, 162-0804
Japan Tokyo, Japan, 167-0051
Japan Tokyo, Japan, 175-0093
Japan Tokyo, Japan, 186-0002